SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
C. Boschi, D. E. Scheim, A. Bancod, M. Millitello, M. Le Bideau, P. Colson, J. Fantini, B. La Scola
This study shows SARS-CoV-2 spike proteins from four lineages induce hemagglutination, with Omicron requiring lower concentrations, and ivermectin inhibits this effect, suggesting therapeutic and safety implications.
bioRxiv · Nov 24, 2022 · PreprintBiochemistry